Novel adjunct therapy to eliminate opioid tolerance and mitigate side effects

submit enquiry
Healthcare & Pharmaceuticals
Healthcare & Pharmaceuticals

University: University of Dundee

Sector(s): Healthcare & Pharmaceuticals

About Opportunity:

Opioids have been used for thousands of years as analgesics. Morphine is still one of the most effective drugs for treating severe pain. Unfortunately, prolonged use of opioids leads to tolerance where increased doses are required to maintain the same level of pain relief. There are currently no alternative analgesics to replace opioids and so an innovative approach is required to develop new drugs or adjunct therapies to mitigate the multiple negative side effects and transform the treatment of severe pain.

Researchers at the University of Dundee have established a method of altering the consequences of opioid receptor activation, potentially eliminating the adverse side effects associated with opioid use. They have shown that mice genetically engineered to lack a protein that regulates receptors in the pain pathway have a negligible tolerance to opioid analgesia. In turn, the researchers have identified a target protein that is recruited to the receptor by the regulatory protein; by inhibiting this target with a drug currently approved for use in patients for a different purpose, the researchers show that opioid analgesic tolerance is eliminated. Ongoing research will determine whether inhibitors of the target protein suppress opioid induced respiratory depression and constipation. The researchers have shown for the first time that inhibition of the target after prolonged morphine treatment can actually reverse established analgesic tolerance. With negligible tolerance and reduced effects of respiratory depression, a regular dose of opioid couldbe administered, substantially decreasing the potential for misuse and overdose. Thesuccessful application of this drug alongside standard opioids as an adjunct therapy mayenable pain relief without debilitating side effects, transforming the management ofsevere and chronic pain.

Key Benefits:

  • Tolerance of opioid analgesia is suppressed
  • Negative side effects of opioids are potentially mitigated
  • Reversal of analgesic tolerance

Applications:

  • Management of severe and chronic pain

IP Status:

This technology is protected by patent application (GB 1608587.0).

Enquiry

Please enter your name.

Please enter the name of the company you work for.

Is your company an SME?

Please select the country you are in.

Please select what part of the UK you are in.

Please select from the following options.

Please enter your email address.

To help us process your enquiry faster please enter some details about the information you are interested in.

Words remaining:

Related Opportunities

  • Telomerase Promoter - Cancer Therapies

    The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.

    Expires: Created:
  • SNP-based assay for analysis of MRSA

    This assay is a rapid and reproducible approach for epidemiological analysis of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates. The assay identifies different strains on EMRSA-15, which is a major cause of hospital acquired MRSA infections in the UK and in other parts of the wo...

    Expires: Created:
  • Catanostics - Non-Invasive Early Stage Cataract Diagnosis & Severity Quantification tool

    Catanostics (Cataract Diagnostics) offers an alternative to the slit lamp currently used for cataract diagnosis before referring a patient for cataract surgery. Our non-invasive fluorescence scan offers "better diagnosis" through non-subjective analysis of data on cataract symptoms & severity lea...

    Expires: Created:
  • Transforming Pharmaceutical Crystal Forms

    The innovation provides a gas-induced method for phase-transforming organic solids, such as pharmaceutical crystals. The inventive method subjects the polymorphs of pharmaceutical agents to various pressures of gases (such as CO2, N2O, and CH4) to induce phase transform with ease.

    Expires: Created:
  • Sperm Motility Enhancers for Assisted Reproductive Technology

    Sperm Motility Enhancers: A Novel Strategy for Assisted Reproductive Technology (ART) based on the direct relationship between human fertility and sperm motility,the University of Dundee has successfully identified FDA-approved compounds with robust and effective stimulation on patient sperm motilit...

    Expires: Created:

Alerts Signup

Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities


Register Now for University Technology.com Alerts


Search Filter

Share this page

Use the buttons below to share these technology opportunities on your favourite social networking site. You can also share them from inside the individual opportunity.